Prevalence and Risk Factors for ASCVD Associated With Hypercholesterolemia - MD Magazine
Yehuda Handelsman, MD: Hello and welcome to this HCPLive® Peer Exchange titled, "Expert Perspective on Novel Treatment Options for Atherosclerotic Cardiovascular Disease and Hypercholesterolemia." I'm Yehuda Handelsman, I'm an endocrinologist in a private practice and I'm associated with Providence Cedars-Sinai Tarzana Medical Center in Los Angeles, California. With me, I have 4 top experts in our field of cardiovascular hyperlipidemia diseases, Drs Christie Ballantyne, Matthew Budoff, Erin Michos, and Paul Jellinger. Would you introduce yourselves? Christie Ballantyne, MD: I'm Christie Ballantyne, the chief of cardiology and cardiovascular research at Baylor College of Medicine in Houston, Texas. Matthew J. Budoff, MD: I'm Matt Budoff, I'm a professor at UCLA [University of California, Los Angeles] School of Medicine and the program director of preventive cardiologists at Harbor-UCLA Medical Center in Torrance, California. Erin D. Michos, MD, MHS: